It can be alarming to see a new spot appear on your skin, especially if it's rapidly growing. Here's what experts need you to ...
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.
The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...
The Sporting News details everything you need to know about McDermott's battle with skin cancer. McDermott first revealed in 2021 that he had squamous cell carcinoma "several times." He added ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results